drugset / Trial / NCT01397994

Study to Assess Efficacy of Nicorandil+Atenolol vs Atenolol in Treatment of Chronic Stable Angina.

NCT01397994

Phase 4 Unknown 40 enrolled Ferozsons Laboratories Ltd.
RandomizedParallel-groupOpen-labelTreatment

Summary

This study is to determine the anti-anginal and anti-ischemic effect of k-channel opener, nicorandil in patients of chronic stable angina.

Timeline

Start
2011-09
Primary completion
2012-01
Completion
2012-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Atenolol Other / unclassified 50 mg
Comparator Nicorandil Other / unclassified 20 mg